scispace - formally typeset
N

Natesa G. Pandian

Researcher at Tufts Medical Center

Publications -  372
Citations -  15825

Natesa G. Pandian is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Mitral valve & Intravascular ultrasound. The author has an hindex of 63, co-authored 368 publications receiving 14965 citations. Previous affiliations of Natesa G. Pandian include Oregon Health & Science University & University of Virginia.

Papers
More filters
Journal ArticleDOI

Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

TL;DR: Identification of LV outflow obstruction with exercise echocardiography may broaden management options in HCM by identifying symptomatic patients not otherwise regarded as potential candidates for septal reduction therapy.
Journal ArticleDOI

Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude

TL;DR: In this paper, the authors evaluated the relationship between changes in pulse wave amplitude (PWA) of the finger and peripheral endothelial function and found that PWA during reactive hyperemia is influenced by factors known to affect vascular function, including cardiovascular risk factors and coronary artery disease.
Journal ArticleDOI

Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography A Scientific Statement From the American Heart Association

TL;DR: This revision of the Jones criteria now brings them into closer alignment with other international guidelines for the diagnosis of acute rheumatic fever by defining high-risk populations, recognizing variability in clinical presentation in these high- risk populations, and including Doppler echocardiography as a tool to diagnose cardiac involvement.
Journal ArticleDOI

Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi.

TL;DR: Comparing regional activities of 201Tl and 99mTc-sestamibi after resting injections in patients with coronary artery disease and regional or global left ventricular dysfunction found the two agents comparably predict reversibility of significant regional wall motion abnormalities after revascularization in such patients to a similar degree.